NuStar Energy L.P. Declares First Quarter 2022 Common Unit Distribution and Series A, Series B and Series C Preferred Units Distributions
SAN ANTONIO–(BUSINESS WIRE)–NuStar Energy L.P. (NYSE: NS) today announced that its Board of Directors has…
Year: 2022
Smartphone Shipments Declined 8.9% in the First Quarter as Global Demand Softens, According to IDC
NEEDHAM, Mass.–(BUSINESS WIRE)–#Apple–Worldwide smartphone shipments declined 8.9% year over year in the first quarter of…
Medical Properties Trust, Inc. Publishes Inaugural Corporate Responsibility Report
BIRMINGHAM, Ala.–(BUSINESS WIRE)–Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced that…
Wilson & Company Names Seven Additional Shareholders to Further Company Growth
Todd Cencimino, Jon Chesser, Catherine Cochrane, Marc Devos, Ed Latimer, Lucas Reed and Amy Straquadine…
Spring Valley Acquisition Corp. Shareholders Approve Business Combination with NuScale Power
Transaction expected to close on May 2, 2022, generating approximately $380 million in gross proceeds…
Finch Therapeutics Announces Removal of FDA Clinical Hold on CP101 IND
SOMERVILLE, Mass., April 28, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…
Aadi Bioscience to Announce First Quarter 2022 Financial Results on May 12, 2022
Company to hold conference call on May 12th at 8:30 am EDT LOS ANGELES, April…
Oncternal Therapeutics to Provide Business Update and Report First Quarter 2022 Financial Results
SAN DIEGO, April 28, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market
MONTREAL, April 28, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the…
Adaptimmune to Report Q1 2022 Financial Results and Business Updates on Monday, May 9, 2022
PHILADELPHIA and OXFORDSHIRE, United Kingdom, April 28, 2022 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP),…
Travere Therapeutics to Report First Quarter 2022 Financial Results
SAN DIEGO, April 28, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Dyadic to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
JUPITER, Fla., April 28, 2022 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”,…
Eagle Pharmaceuticals to Host First Quarter 2022 Financial Results on May 9, 2022
WOODCLIFF LAKE, N.J., April 28, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (“Eagle” or the…
Genocea Initiates Restructuring and Announces Plan to Explore Strategic Alternatives
CAMBRIDGE, Mass., April 28, 2022 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical…
ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report on Form 20-F, as well as its 2022 financial calendar
ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report on Form 20-F,…
Relay Therapeutics to Announce First Quarter 2022 Financial Results and Corporate Highlights
CAMBRIDGE, Mass., April 28, 2022 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage…
Histogen to Report First Quarter 2022 Financial Results and Provide Business Update
SAN DIEGO, April 28, 2022 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics…
Seer to Present at the BofA Securities 2022 Healthcare Conference
REDWOOD CITY, Calif., April 28, 2022 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life…
Cypherpunk Holdings Host an Investor Webinar on May 06, 2022
Toronto, Ontario–(Newsfile Corp. – April 28, 2022) – Cypherpunk Holdings Inc. (CSE: HODL) (OTC Pink:…
Burn Floki Introduces a Play2Earn Platform, Becoming Gateway for Revenue
New York, New York–(Newsfile Corp. – April 28, 2022) – Burn Floki, a new Play2Earn…